The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
| Date first appeared online | 15/12/2020 |
| DOI | 10.1007/s13300-020-00981-0 |
| Authors | Min T., Bain S. |
| Journal Name | Diabetes Therapy |
| Volume | 12 |
Documents
- 55784.pdf , Book, ©The Author(s) 2020. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License